Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets.
Read More…
Industry, Sector and Symbol
Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Phone980-299-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.37 billion
Profitability
Miscellaneous
Employees5,900
Next Earnings Date11/6/2019 (Estimated)
OptionableOptionable
Albemarle (NYSE:ALB) Frequently Asked Questions
What is Albemarle's stock symbol?
Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."
How often does Albemarle pay dividends? What is the dividend yield for Albemarle?
Albemarle declared a quarterly dividend on Wednesday, July 24th. Stockholders of record on Friday, September 13th will be given a dividend of $0.3675 per share on Tuesday, October 1st. This represents a $1.47 annualized dividend and a dividend yield of 2.18%. The ex-dividend date of this dividend is Thursday, September 12th. View Albemarle's Dividend History.
How were Albemarle's earnings last quarter?
Albemarle Co. (NYSE:ALB) issued its quarterly earnings results on Wednesday, August, 7th. The specialty chemicals company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.41 by $0.14. The specialty chemicals company earned $885.05 million during the quarter, compared to the consensus estimate of $893.50 million. Albemarle had a return on equity of 15.71% and a net margin of 16.01%. Albemarle's revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.36 earnings per share. View Albemarle's Earnings History.
When is Albemarle's next earnings date?
What guidance has Albemarle issued on next quarter's earnings?
Albemarle updated its FY19 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $6.25-6.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.18. The company issued revenue guidance of $3.65-3.85 billion, compared to the consensus revenue estimate of $3.67 billion.
What price target have analysts set for ALB?
19 equities research analysts have issued 1 year price targets for Albemarle's stock. Their predictions range from $39.50 to $128.00. On average, they expect Albemarle's share price to reach $88.7778 in the next twelve months. This suggests a possible upside of 31.5% from the stock's current price. View Analyst Price Targets for Albemarle.
What is the consensus analysts' recommendation for Albemarle?
19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 3 sell ratings, 5 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.
Has Albemarle been receiving favorable news coverage?
Media headlines about ALB stock have trended negative on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Albemarle earned a daily sentiment score of -2.9 on InfoTrie's scale. They also gave news articles about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Albemarle.
Are investors shorting Albemarle?
Albemarle saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 17,875,100 shares, an increase of 7.6% from the July 31st total of 16,612,100 shares. Based on an average daily volume of 1,420,000 shares, the days-to-cover ratio is currently 12.6 days. Approximately 17.0% of the shares of the company are sold short. View Albemarle's Current Options Chain.
Who are some of Albemarle's key competitors?
What other stocks do shareholders of Albemarle own?
Who are Albemarle's key executives?
Albemarle's management team includes the folowing people:
- Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
- Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
- Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
- Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
- Mr. David Ryan, VP of Corp. Strategy & Investor Relations
Who are Albemarle's major shareholders?
Albemarle's stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (12.02%), BlackRock Inc. (7.84%), BlackRock Inc. (7.83%), Primecap Management Co. CA (5.45%), Baillie Gifford & Co. (2.53%) and Bank of New York Mellon Corp (2.11%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold and Scott Tozier. View Institutional Ownership Trends for Albemarle.
Which institutional investors are selling Albemarle stock?
ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Jennison Associates LLC, Jennison Associates LLC, Robecosam AG, United Services Automobile Association, Bank of America Corp DE, Zurcher Kantonalbank Zurich Cantonalbank and Janus Henderson Group PLC. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.
Which institutional investors are buying Albemarle stock?
ALB stock was bought by a variety of institutional investors in the last quarter, including Primecap Management Co. CA, Sterling Capital Management LLC, BlackRock Inc., BlackRock Inc., Invesco Ltd., AXA, Nuveen Asset Management LLC and Grantham Mayo Van Otterloo & Co. LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.
How do I buy shares of Albemarle?
Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Albemarle's stock price today?
One share of ALB stock can currently be purchased for approximately $67.52.
How big of a company is Albemarle?
Albemarle has a market capitalization of $7.16 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.
What is Albemarle's official website?
How can I contact Albemarle?
Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]
MarketBeat Community Rating for Albemarle (NYSE ALB)
MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.
